AgomAb Therapeutics NV AGMB
—
10.51
(0.07)
(0.66%)
as of 25 Sep
- Market cap
- $521.1M
- P/E
- —
Follow AGMB
| Jun '26 | Dec '25 | Sep '25 | Dec '24 | |
|---|---|---|---|---|
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
0.00 | — | — | — |
Free Cash Flow |
(144.00) | — | — | — |
Piotroski F-Score |
0.00 | — | — | — |
| Other line items | ||||
Cash ROIC |
(23.90%) | 0.00% | 0.00% | 0.00% |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | — | — | — |
Depreciation/Fixed assets |
1.53 | 0.00 | — | 0.00 |
Capex/Depreciation |
0.00 | — | — | — |
Operating CF per Share |
0.00 | — | — | — |
Columns are period end dates